EMN
EASTMAN CHEMICAL COPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 5 ▼ 1 insider sell $131.7K at $77.05
- Aug 4 ▼ 1 insider sell $234.1K at $71.31
- Sep 11 Keybanc initiates
- Oct 13 Barclays initiates
- Oct 16 ▼ JP Morgan downgrades
- Oct 29 ▼ Earnings: EMN Q3 2026 Earnings: EPS $1.84 (-5.1% vs est)
- Nov 6 ▲ 1 insider buy $160.0K at $65.28
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $160.0K at an average $65.28. 1 insider sold $365.8K.
- InstitutionsBULLISH
Q3 2026: 49 added (2 new), 24 trimmed or exited. Largest new: Squarepoint Ops $28.4M, Qube Research & Technologies $11.6M.
- AnalystsBULLISH
11 of 23 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest −11.4% to 5.54M shares. 3.5 days to cover, ≈4.8% of shares.
- TrendRANGE
3% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Boston Partners | ADD | $181.2M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $92.7M |
| UBS Group AG | ADD | $81.4M |
| Quantinno Capital Management LP | DOUBLED | $51.8M |
| MACKENZIE FINANCIAL CORP | DOUBLED | $49.1M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | $44.8M |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | $35.3M |
| Squarepoint Ops LLC | NEW | $28.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
23 analystsPrice is below the lowest target. Median implies +20%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 4, 2026 | RBC Capital MAINTAIN | Sector Perform |
| Nov 3, 2026 | Citigroup MAINTAIN | Buy |
| Nov 2, 2026 | Barclays MAINTAIN | Equal-Weight |
| Nov 2, 2026 | JP Morgan MAINTAIN | Neutral |
| Oct 16, 2026 | JP Morgan DOWNGRADE | Neutral |
| Oct 13, 2026 | RBC Capital MAINTAIN | Sector Perform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
McAlindon Julie A. SVP, Regions & Chf SupChn Ofcr Nov 6, 2026 | BUY | $160.0K |
OBRIEN JAMES J /KY Director Oct 7, 2026 | AWARD | 480 sh |
SLAGER DONALD W Director Oct 7, 2026 | AWARD | 480 sh |
Mink Kim Ann Director Oct 7, 2026 | AWARD | 480 sh |
BEGEMANN BRETT D Director Oct 7, 2026 | AWARD | 480 sh |
Alfonso Humberto P Director Oct 7, 2026 | AWARD | $73.5K |
Alfonso Humberto P Director Oct 7, 2026 | AWARD | 480 sh |
BEGEMANN BRETT D Director Oct 7, 2026 | AWARD | $86.1K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
7 filings · 0 bullish · 1 bearish · 6 neutral- NEUTRAL 8-KNov 12, 2026
Eastman Chemical issued $300 million of 5.500% senior unsecured notes due 2030, completing a debt…
Monitor next quarterly report for how proceeds are deployed, particularly whether debt repayment or capex dominates. The timing of this raise shortly after an earnings miss and guidance cut suggests…
- NEUTRAL 424B5Nov 3, 2026
Eastman Chemical issued $300 million of 5.500% senior unsecured notes due 2030 in an underwritten…
The debt raise adds $300M to Eastman's $5.2B of pari passu debt, increasing leverage modestly. Monitor upcoming quarterly filings for any change in leverage ratios or debt repayment plans. The…
- NEUTRAL 424B5Nov 2, 2026
Eastman Chemical filed a preliminary prospectus supplement for an underwritten public offering of…
Monitor the final pricing supplement for the note size, coupon, and maturity. The timing of this debt offering so soon after a Q3 earnings miss and lowered guidance suggests potential cash flow…
- BEARISH 8-KOct 29, 2026
Eastman Chemical reported Q3 2026 adjusted EPS of $1.84, missing the $1.92 consensus by 4.2%…
The EPS miss and soft Q4 guidance signal margin pressure from rising input costs and seasonal demand weakness. Watch the Q4 earnings call for updates on price-cost recovery and the pace of working…
All EMN filing & press-release reports (7)
- 8-K reportNov 12, 2026
- 424B5 reportNov 3, 2026
- 424B5 reportNov 2, 2026
- 8-K reportOct 29, 2026
- INST-CLUSTER reportOct 21, 2026
- 8-K reportOct 20, 2026
- DEFA14A reportMar 24, 2026